Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000903423-16-001314

Options or other derivatives

  • 10% owner acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
GLAXOSMITHKLINE PLC 10% owner 2016-10-18 Grant or award · Stock Option +30,000 30,000 I
Loading xslF345X03/glaxo-crispr.xml…